A Retrospective Chart Review of Contraceptive Use among Adolescents with Opioid Use Disorder - 20/03/18
, Brittny E. Manos, BA 2, Elise D. Berlan, MD, MPH 1, 3, Andrea E. Bonny, MD 1, 2, 3Abstract |
Study Objective |
To describe contraceptive use among female adolescents initiating outpatient treatment for opioid use disorder.
Design |
Retrospective chart review.
Setting |
Outpatient clinic providing medication-assisted treatment for substance use disorders to adolescents and young adults.
Participants |
Nonpregnant female adolescents who presented for treatment from January 1, 2013 to January 31, 2016 (N = 123).
Interventions |
None.
Main Outcome Measures |
Prescription contraceptive use at baseline and initiation of a new method within 90 days.
Results |
Of 123 female adolescents who presented for treatment of opioid use disorder, 113 (91.9%) reported sexual activity and 80 (65.0%) were not using prescription contraception at intake. Previous pregnancy was reported by 43 (35.0%) and 20 (16.3%) were positive for a sexually transmitted infection. Contraceptive counseling was not documented for 73 (59.3%) patients. Among patients with no prescription contraception at baseline, 56 of 80 (70.0%) initiated a method within the study window. Significant predictors (odds ratio [OR]; 95% confidence interval) of contraceptive initiation included previous pregnancy (8.6; 1.39-52.99), education of less than a high school diploma/general equivalency diploma (7.4; 1.63-33.41), and return for follow-up visit (9.8; 2.18-43.69).
Conclusion |
Young women who presented for opioid use disorder treatment were at high risk of adverse reproductive health outcomes. Most were sexually active and not using prescription contraception. Findings underscore the need for contraceptive counseling in this patient population. Optimally, these services would be provided in conjunction with substance use treatment. Improved contraceptive counseling documentation will allow evaluation of effective contraceptive counseling strategies for adolescents with opioid use disorders and might serve to inform future interventions.
Le texte complet de cet article est disponible en PDF.Key Words : Adolescent medicine, Opioid use disorder, Contraception, Reproductive health
Plan
| Dr Berlan receives honoraria from Merck & Co for being a Nexplanon trainer. The remaining authors indicate no conflicts of interest. |
Vol 31 - N° 2
P. 122-127 - avril 2018 Retour au numéro
Article précédent
- “It's Pretty Hard to Tell Your Mom and Dad That You're on a Method”: Exploring How an App Could Promote Adolescents' Communication with Partners and Parent(s) to Increase Self-Efficacy in Long-Acting Reversible Contraception Use
- Emily B. Shakibnia, Sarah E. Timmons, Melanie A. Gold, Samantha Garbers
- Bits and Pieces: A Crowd-Sourced Series of 54 Cases of Fractured Hormonal Implants
- Bonnie C. Crouthamel, Melissa A. Schiff, Anne-Marie E. Amies Oelschlager, Sarah W. Prager, Katherine E. Debiec
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?